Clinical effectiveness of Tui Na for insomnia compared with estazolam: A systematic review and meta-analysis of randomized controlled trials
- PMID: 31779989
- DOI: 10.1016/j.ctim.2019.08.020
Clinical effectiveness of Tui Na for insomnia compared with estazolam: A systematic review and meta-analysis of randomized controlled trials
Abstract
Objective: The purpose of this systematic review (SR) is to evaluate the effectiveness and safety of Tui Na therapy for insomnia.
Methods: Two authors separately searched PubMed, the Cochrane Library, EMBASE, SinoMed Database, China National Knowledge Infrastructure (CNKI), Wanfang Database, China Science Technology Journal Database, related SR and published protocols at the same time to find randomized controlled trials (RCTs), which compared Tui Na therapy with estazolam therapy for insomnia, from their inception to January1st 2019. Screening documents, data extraction, quality assessment of methodology and quality assessment of evidence were also conducted by two authors separately at the same time. We used Cochrane Risk of Bias tool to assess the methodological quality of included RCTs. The results of meta-analysis were made via RevMan software (5.3). The quality of evidence was assessed by on-line GRADEpro. The primary outcome: Pittsburgh Sleep Quality Index (PSQI) score, the secondary outcome: clinical effectiveness rate and the safety index: adverse events. The clinical effectiveness of these included RCTs all focused on the improvement of patients' satisfaction with sleep time and sleep quality.
Results: We included 22 RCTs(1,999 participants), meeting the inclusion and exclusion criteria. The assessment of methodological quality was not satisfied, in which "high risk", "unclear risk" and "low risk" all existed. The results of meta-analysis demonstrated that (1)for primary outcome, the PSQI score of Tui Na therapy was lower than that of estazolam therapy after treatment in subgroup1(Head)(MD-2.39,95%CI[-3.79,-0.98],I2 = 82%,n = 291,3 trials) and subgroup4(Abdomen)(MD-1.7,95%CI[-2.53,-0.87],I2 = 0%,n = 120,2 trials);while there was no significant difference between Tui Na therapy and estazolam therapy in subgroup2(Head and trunk)(MD-1.39,95%CI[-3.03,0.24],I2 = 90%,n = 200, 2 trials) and subgroup3(Head, trunk and extremities)(MD-0.51,95%CI[-1.53,0.5],I2 = 30%,n = 126,2 trials).(2) for secondary outcomes(the clinical effectiveness rate and safety index),the clinical effectiveness rate of Tui Na therapy was higher than that of estazolam therapy after treatment in subgroup1(Head)(RR1.21,95%CI[1.05,1.39],I2 = 26%,n = 239,3 trials), subgroup2(Head and trunk)(RR1.15,95%CI[1.08,1.23],I2 = 33%,n = 1024,10 trials) and subgroup4(Abdomen)(RR1.12,95%CI[1.01,1.23],I2 = 0%,n = 180,3 trials); while there was no significant difference between Tui Na therapy and estazolam therapy in subgroup3(Head, trunk and extremities)(RR1.03,95%CI[0.94,1.13],I2 = 28%,n = 346,4 trials).Safety index, 5 RCTs reported adverse events. Among them, only 1 RCT reported adverse event in Tui Na therapy, which was daytime drowsiness; all 5 RCTs reported adverse events in estazolam therapy, which were dry mouth, dizziness, daytime drowsiness etc. The evidence quality was generally low to very low.
Conclusion: Tui Na therapy appeared to be superior to estazolam therapy in treating areas(head; abdomen), while there was no significant difference between Tui Na therapy and estazolam therapy in treating areas(head and trunk; head, trunk and extremities). No serious adverse event was reported in Tui Na therapy. However the methodological quality and evidence quality were not satisfied. Therefore we could not make a convincing conclusion on the effectiveness and safety of Tui Na therapy for insomnia. Practitioners should combine their experience, evidence of our review and patients' preferences to make a proper treatment. And more high quality RCTs and well-designed protocols of Tui Na therapy for insomnia are needed in the future.
Keywords: Estazolam; Insomnia; Meta-analysis; Randomized controlled trial; Systematic review; Tui Na.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Pediatric Tui Na for acute diarrhea in children under 5 years old: A systematic review and meta-analysis of randomized clinical trials.Complement Ther Med. 2018 Dec;41:10-22. doi: 10.1016/j.ctim.2018.08.011. Epub 2018 Aug 30. Complement Ther Med. 2018. PMID: 30477824
-
Acupuncture for Primary Insomnia: An Updated Systematic Review of Randomized Controlled Trials.J Altern Complement Med. 2019 May;25(5):451-474. doi: 10.1089/acm.2018.0046. Epub 2019 Apr 23. J Altern Complement Med. 2019. PMID: 31013432
-
Acupuncture for cancer-related insomnia: A systematic review and meta-analysis.Phytomedicine. 2022 Jul 20;102:154160. doi: 10.1016/j.phymed.2022.154160. Epub 2022 May 14. Phytomedicine. 2022. PMID: 35636168 Review.
-
A comprehensive insight on cognitive behavioral therapy for insomnia in pregnant women: A systematic review and meta-analysis.Sleep Med. 2023 Dec;112:322-332. doi: 10.1016/j.sleep.2023.11.002. Epub 2023 Nov 4. Sleep Med. 2023. PMID: 37952481 Review.
-
Efficacy and safety of Wuling capsule for insomnia disorder: a systematic review and meta-analysis of randomized controlled trials.Sleep Med. 2022 May;93:1-14. doi: 10.1016/j.sleep.2022.03.014. Epub 2022 Mar 24. Sleep Med. 2022. PMID: 35397258
Cited by
-
Effectiveness of Acupuncture, Mind and Body Practices, and Natural Products for Insomnia: an overview of systematic reviews.J Pharmacopuncture. 2022 Sep 30;25(3):186-198. doi: 10.3831/KPI.2022.25.3.186. J Pharmacopuncture. 2022. PMID: 36186098 Free PMC article. Review.
-
Comparative Effectiveness of Western and Eastern Manual Therapies for Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-Analysis.Healthcare (Basel). 2021 Aug 30;9(9):1127. doi: 10.3390/healthcare9091127. Healthcare (Basel). 2021. PMID: 34574903 Free PMC article. Review.
-
Suan-Zao-Ren decoction for insomnia: A protocol for a systematic review and meta-analysis.Medicine (Baltimore). 2020 Aug 21;99(34):e21658. doi: 10.1097/MD.0000000000021658. Medicine (Baltimore). 2020. PMID: 32846778 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials